Association of Lowering Low‐Density Lipoprotein Cholesterol With Contemporary Lipid‐Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta‐Analysis

Association of Lowering Low‐Density Lipoprotein Cholesterol With Contemporary Lipid‐Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta‐Analysis

Background The relationship between lowering LDL (low‐density lipoprotein) cholesterol with contemporary lipid‐lowering therapies and incident diabetes mellitus (DM) remains uncertain. Methods and Results Thirty‐three randomized controlled trials (21 of statins, 12 of PCSK9 [proprotein convertase su...

Full description

Bibliographic Details
Main Authors: Safi U. Khan, Hammad Rahman, Victor Okunrintemi, Haris Riaz, Muhammad Shahzeb Khan, Sudhakar Sattur, Edo Kaluski, A. Michael Lincoff, Seth S. Martin, Michael J. Blaha
Format: Article
Language:English
Published: Wiley 2019-04-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
diabetes mellitus
LDL (low‐density lipoprotein) cholesterol
PCSK9 (proprotein convertase subtilisin/kexin type 9)
statin
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.118.011581

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.118.011581

Similar Items